United States· US:0220-1083_f2b88588-8e8b-43f8-e053-2a95a90a0ba6
Cantharis
A medicinal product containing lytta vesicatoria, registered in United States by Boiron.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LYTTA VESICATORIA
- Manufacturer
- Boiron
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1102201083416 [hp_C] in 1 TUBE (0220-1083-41)
- ndc110220-1083-41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lytta vesicatoria in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/10878e47-70c7-463e-9ce4-3029c51b1e35 GET /v1/drugs/10878e47-70c7-463e-9ce4-3029c51b1e35?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "6",
"substance": "LYTTA VESICATORIA",
"productndc": "0220-1083",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/6[hp_C]",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about lytta vesicatoria.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.